BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
13 results:

  • 1. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
    Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
    BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with pancreatic Adenocarcinoma.
    Dong Y; Tian J; Yan B; Lv K; Li J; Fu D
    Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for pai-1.
    Durlanik S; Fundel-Clemens K; Viollet C; Huber HJ; Lenter M; Kitt K; Pflanz S
    Sci Rep; 2021 Jul; 11(1):14849. PubMed ID: 34290311
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, pai1 and IGFBP1.
    Li X; Niu N; Sun J; Mou Y; He X; Mei L
    FEBS Open Bio; 2020 Dec; 10(12):2687-2701. PubMed ID: 33064893
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric cancer.
    Meng C; Xia S; He Y; Tang X; Zhang G; Zhou T
    Comput Math Methods Med; 2020; 2020():5479279. PubMed ID: 32908579
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. pancreatic stellate cells activated by mutant KRAS-mediated pai-1 upregulation foster pancreatic cancer progression via IL-8.
    Wang HC; Lin YL; Hsu CC; Chao YJ; Hou YC; Chiu TJ; Huang PH; Tang MJ; Chen LT; Shan YS
    Theranostics; 2019; 9(24):7168-7183. PubMed ID: 31695760
    [No Abstract]    [Full Text] [Related]  

  • 7. TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer.
    Melisi D; Garcia-Carbonero R; Macarulla T; Pezet D; Deplanque G; Fuchs M; Trojan J; Kozloff M; Simionato F; Cleverly A; Smith C; Wang S; Man M; Driscoll KE; Estrem ST; Lahn MMF; Benhadji KA; Tabernero J
    Cancer Chemother Pharmacol; 2019 May; 83(5):975-991. PubMed ID: 30887178
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable pancreatic Ductal Adenocarcinoma.
    Liu WJ; Zhou L; Liang ZY; Zhou WX; You L; Zhang TP; Zhao YP
    Chin Med J (Engl); 2018 Dec; 131(24):2947-2952. PubMed ID: 30539907
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.
    Georgiadou D; Sergentanis TN; Sakellariou S; Filippakis GM; Zagouri F; Vlachodimitropoulos D; Psaltopoulou T; Lazaris AC; Patsouris E; Zografos GC
    Eur J Surg Oncol; 2014 Oct; 40(10):1331-7. PubMed ID: 24480377
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma cells.
    Lupu-Meiri M; Geras-Raaka E; Lupu R; Shapira H; Sandbank J; Segal L; Gershengorn MC; Oron Y
    J Cell Physiol; 2012 Nov; 227(11):3621-8. PubMed ID: 22331587
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model.
    Niedergethmann M; Alves F; Neff JK; Heidrich B; Aramin N; Li L; Pilarsky C; Grützmann R; Allgayer H; Post S; Gretz N
    Br J Cancer; 2007 Nov; 97(10):1432-40. PubMed ID: 17940512
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High expression of plasminogen activator inhibitor-2 (pai-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma.
    Smith R; Xue A; Gill A; Scarlett C; Saxby A; Clarkson A; Hugh T
    World J Surg; 2007 Mar; 31(3):493-502; discussion 503. PubMed ID: 17219285
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression.
    Schwarte-Waldhoff I; Klein S; Blass-Kampmann S; Hintelmann A; Eilert C; Dreschers S; Kalthoff H; Hahn SA; Schmiegel W
    Oncogene; 1999 May; 18(20):3152-8. PubMed ID: 10340387
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.